Hitachi develops interventional Airis II
Hitachi Medical Systems America in Twinsburg, OH, has developed an interventional version of its Airis II open MRI scanner. The system has been installed in a specially designed suite at the Neuroscience Institute of the University Hospital in
Hitachi Medical Systems America in Twinsburg, OH, has developed an interventional version of its Airis II open MRI scanner. The system has been installed in a specially designed suite at the Neuroscience Institute of the University Hospital in Cincinnati, where radiologists are using it for both conventional imaging procedures as well as MR-guided surgical applications.
Hitachi's interventional package for Airis II uses special software and hardware to support surgical procedures, such as fluoroscopic imaging sequences, open-designed radio-frequency coils, a 20-in LCD monitor located in the imaging suite, and special non-ferromagnetic surgical tools. Hitachi plans to file a 510(k) application for the interventional package and sell it as an option for Airis II, according to Sheldon Schaffer, Hitachi vice president of marketing.
At the Neuroscience Institute, Hitachi has worked with the hospital to develop a special imaging suite for the system, which includes features such as a 20-inch deep pit in which surgeons and radiologists stand while performing imaging procedures. A custom stainless steel lift transports equipment in and out of the surgical pit, while a neurosurgical operating room is adjacent to the imaging suite.
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
